Skip to main content
. 2018 Jan 3;32(2):253–260. doi: 10.1097/QAD.0000000000001700

Table 2.

Prevalence of cardiovascular risk factors among patients and controls stratified by age.

Patients Controls
Risk factors 30–44 (n = 139) % (95% CI) 45–59 (n = 202) % (95% CI) ≥60 (n = 38) % (95% CI) Total 30–44 (n = 116) % (95% CI) 45–59 (n = 121) % (95% CI) ≥60 (n = 119) % (95% CI) Total
BMI (kg/m2):
 Overweight (≥25 < 30) 15.1 (10.1–22.1) 12.4 (8.5–17.7) 5.3 (1.3–18.8) 12.7 (9.7–16.4) 14.8 (9.4–22.5) 18.3 (12.4–26.3) 12.6 (7.7–19.9) 15.3 (11.9–19.4)
 Obese (≥30) 2.2 (0.7–6.5) 8.4 (5.3–13.1) 5.3 (1.3–18.8) 5.8 (3.8–8.7) 7.0 (3.5–13.3) 11.7 (7.0–18.8) 3.3 (1.3–8.6) 7.3 (5.0–10.6)
Waist–hip ratio
 >0.95 (male) and >0.85 (female) 41.0 (33.1–49.4) 42.1 (35.5–49.0) 42.1 (27.6–58.1) 41.7 (36.8–46.7) 30.2 (22.5–39.1) 38.8 (30.6–47.8) 30.3 (22.7–39.1) 33.2 (28.4–38.2)
SBP (mmHg):
 140–159 1.4 (0.4–5.6) 9.5 (6.1–14.4) 31.6 (18.9–47.8) 8.7 (6.3–12.0) 3.5 (1.3–9.0) 17.5 (11.7–25.4) 24.4 (17.5–32.9) 15.3 (11.9–19.5)
 160–179 1.4 (0.4–5.6) 4.5 (2.3–8.4) 2.6 (0.4–16.5) 3.2 (1.8–5.5) 0 5.8 (2.8–11.8) 9.2 (5.2–15.9) 5.1 (3.2–8.0)
 ≥180 0 1.0 (0.2–3.9) 5.3 (1.3–18.8) 1.1 (0.4–2.8) 0 0 7.5 (4.0–13.9) 2.5 (1.3–4.8)
SBP ≥140 mmHg 2.9 (1.1–7.4) 14.9 (10.6–20.6) 39.5 (25.4–55.6) 13.0 (9.9–16.8) 3.5 (1.3–9.0) 23.3 (16.6–31.7) 41.2 (32.7–50.2) 23.0 (18.9–27.6)
DBP (mmHg)
 90–99 8.6 (5.0–14.6) 11.9 (8.1–17.2) 15.8 (7.3–31.0) 11.1 (8.3–14.7) 6.1 (3.0–12.3) 13.3 (8.3–20.7) 19.3 (13.2–27.4) 13.0 (9.9–17.0)
 100–109 1.4 (0.4–5.6) 4.5 (2.3–8.4) 10.5 (4.0–24.9) 4.0 (2.4–6.5) 0 4.2 (1.7–9.6) 5.9 (2.8–11.8) 3.4 (1.9–5.9)
 ≥110 0 1.5 (0.5–4.5) 2.6 (0.4–16.5) 1.1 (0.4–2.8) 0 0 5.9 (2.8–11.8) 2.0 (0.9–4.1)
 DBP ≥90 mmHg 10.1 (6.0–16.3) 17.9 (13.2–23.9) 29.0 (16.8–45.1) 16.1 (12.8–20.2) 6.1 (3.0–12.3) 17.5 (11.7–25.4) 31.1 (23.4–40.0) 18.4 (14.7–22.8)
 Hypertension (BP ≥140/90 mmHg) 10.8 (6.6–17.2) 20.4 (15.4–26.6) 44.7 (29.9–60.6) 19.3 (15.6–23.6) 6.1 (3.0–12.3) 25.8 (18.8–34.4) 42.9 (34.3–51.9) 25.2 (21.0–30.0)
Self- reported history of hypertension 5.0 (2.4–10.2) 14.1 (9.9–19.4) 34.2 (21.0–50.5) 12.8 (9.7–16.6) 9.2 (5.0–16.2) 32.1 (24.2–41.3) 37.6 (29.3–46.7) 26.6 (22.2–31.6)
Total cholesterol
 ≥200 mg/dl: 10.1 (6.1–16.4) 19.8 (14.9–25.9) 26.3 (14.8–42.1) 16.9 (13.5–21.1) 2.6 (0.8–7.9) 16.7 (11.0–24.5) 17.7 (11.8–25.6) 12.5 (9.4–16.4)
 Median TC: mg/dl (IQR) 140.5 (110–175) 154 (118–187) 166 (137–202) 151 (115–181) 131 (103–169) 152 (115.5–186.5) 148 (114–185) 144 (111–180)
LDL cholesterol
 ≥130 mg/dl: 8.0 (4.5–13.9) 15.4 (11.1–21.1) 23.7 (12.8–39.6) 13.6 (10.5–17.4) 1.8 (0.4–6.8) 12.5 (7.7–19.7) 11.8 (7.1–18.9) 8.8 (6.2–12.2)
 Median LDL (IQR) 77 (59–104) 88 (65–116) 96.5 (66–128) 85 (63–111) 71.5 (55–92) 86.5 (63.5–110) 84 (63–109) 80 (61–106)
HDL cholesterol
 <40 (male)/<50 (female) 53.6 (45.3–61.8) 49.0 (42.1–55.9) 34.2 (21.0–50.5) 49.2 (44.1–54.3) 57.0 (47.8–65.8) 52.5 (43.6–61.3) 49.6 (40.7–58.5) 53.0 (47.7–58.1)
 Median HDL female (IQR) 45 (35–60) 47 (34–65) 60 (43–69) 47 (35–63) 46 (35–54) 46 (35.5–58) 45.5 (33–59) 46 (35–58)
 Median HDL male (IQR) 46 (35–62) 46 (39–59) 45 (31–62) 46 (38–60) 41.5 (32–54) 46.5 (32–58.5) 43 (32–57) 43 (32–57)
Triglycerides
 ≥150 mg/dl 13.0 (8.3–19.6) 19.3 (14.4–25.4) 10.5 (4.0–24.9) 16.1 (12.7–20.2) 7.8 (4.1–12.3) 19.0 (13.0–27.0) 12.6 (7.7–19.9) 13.2 (10.1–17.1)
 Median TG (IQR) 76 (48–116) 88.5 (63–129) 87.5 (65–132) 84 (60–126) 77.5 (53–105) 92 (63.5–132.5) 91 (69–121) 66 (63–121)
HbA1c
 6.0–6.4% 6.5 (3.4–12.0) 7.9 (4.9–12.6) 10.5 (4.0–24.9) 7.7 (5.4–10.8) 3.5 (1.3–8.8) 5.8 (2.8–11.8) 6.8 (3.4–13.0) 5.4 (3.4–8.3)
 ≥6.5% 5.0 (2.4–10.2) 6.4 (3.8–10.8) 13.2 (5.6–28.0) 6.6 (4.5–9.6) 3.4 (1.3–8.8) 4.2 (1.7–9.6) 1.7 (0.4–6.5) 3.1 (1.7–5.5)
Current smoker
2.2 (0.7–6.5) 2.5 (1.0–5.8) 2.6 (0.4–16.5) 2.4 (1.2–4.5) 2.6 (0.8–7.7) 4.1 (1.7–9.6) 8.4 (4.6–14.9) 5.1 (3.2–7.9)

BP, blood pressure; CI, confidence interval; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; IQR, interquartile range; LDL, low-density lipoprotein; TC, total cholesterol; TG, triglycerides.